BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 3327820)

  • 1. Comparison of betamethasone dipropionate (0.05%) and betamethasone valerate (0.1%) ointments in psoriasis and other dermatoses--a multicentric double-blind clinical study.
    Sharma SD
    Indian J Dermatol; 1986; 31(2-3):34-7. PubMed ID: 3327820
    [No Abstract]   [Full Text] [Related]  

  • 2. Betamethasone dipropionate (0.05)% plus chinoform (3%) cream against betamethasone valerate (0.1%) plus chinoform cream (3%) in secondarily infected dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Jul; 32(3):73-6. PubMed ID: 2973437
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of psoriasis with 0.1% domoprednate (a D-homocorticosteroid) and 0.1% betamethasone valerate ointment. A double-blind, randomized trial.
    Christiansen JV; Foged E; Holm P; Jørgensen AS; Reymann F
    Dermatologica; 1985; 170(4):195-8. PubMed ID: 3888709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diprosone (betamethasone dipropionate) Creame 0-05%. Review and report of a multicentre study.
    Chambers WB; Cash WS; Marinaccio A
    J Int Med Res; 1976; 4(3 Suppl):1-26. PubMed ID: 799993
    [No Abstract]   [Full Text] [Related]  

  • 5. Diprosone (betamethasone dipropionate) cream 0.05%. A review and interim report of a comparative multi-centre study versus betamethasone valerate 0.1%.
    Rhodes EL; Scott LV
    Br J Clin Pract; 1983 Apr; 37(4):130-2. PubMed ID: 6349670
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of halcinonide and betamethasone valerate. Use with occlusive dressings in psoriasis treatment.
    Clark RF; Clement ER
    Arch Dermatol; 1975 Jun; 111(6):731-3. PubMed ID: 1094960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etretinate (Tigason) and betamethasone valerate (Celeston valerate) in the treatment of psoriasis. A double-blind, randomized, multicenter trial.
    Christiansen JV; Holm P; Møller R; Reymann F; Schmidt H
    Dermatologica; 1982 Sep; 165(3):204-7. PubMed ID: 6751889
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 10. [Double-blind evaluation of the effectiveness and tolerance of tipredane cream and betamethasone valerate cream in patients with psoriasis].
    Damasio M; Tacchini GA
    G Ital Dermatol Venereol; 1988 Sep; 123(9):IL-LI. PubMed ID: 3243575
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of erythrosquamous dermatoses. Betamethasone dipropionate plus salicylic acid in comparison with betamethasone dipropionate solution].
    Nolting S; Hagemeier HH
    Fortschr Med; 1983 Oct; 101(37):1679-83. PubMed ID: 6227542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind clinical comparisons of topical betamethasone valerate and betamethasone benzoate in the treatment of steroid-responsive dermatoses.
    Hall-Smith P
    Br J Clin Pract; 1972 Sep; 26(9):422-3. PubMed ID: 4562674
    [No Abstract]   [Full Text] [Related]  

  • 13. Amcinonide vs. betamethasone dipropionate ointments in the treatment of psoriasis.
    Huntley AC; Isseroff R
    Cutis; 1985 May; 35(5):489-92. PubMed ID: 3891239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Betamethasone dipropionate (0.05%) plus salicylic acid (3%) ointment versus dexamethasone trimethyl acetate (1%) and salicylic acid 4% ointments in chronic dermatoses.
    Chattopadhyay SP; Arora PN; Anand S; Sharma SD
    Indian J Dermatol; 1987 Apr; 32(2):41-4. PubMed ID: 3453353
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmented betamethasone: efficacy in psoriasis with different dosing frequencies.
    Singh S
    Arch Dermatol; 1996 Dec; 132(12):1525-6. PubMed ID: 8961896
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hydrocortisone butyrate (Locoid) compared with betamethasone valerate. A controlled clinical trail].
    Thormann J
    Ugeskr Laeger; 1976 Jan; 138(4):214-6. PubMed ID: 766347
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind comparison of betamethasone dipropionate 0.05% cream versus beclomethasone dipropionate 0.025% cream in steroid-responsive dermatoses.
    Oberai C
    Indian J Dermatol; 1988 Oct; 33(4):61-5. PubMed ID: 3075599
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical treatment of exzema with flupamesone (Flutenal);a double-blind comparison with bethamethasone-17-valerate. (method of simultaneous symmetrical paired comparisons).
    Moreno TR; Canas TR; Mestre JM
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):183-6. PubMed ID: 403053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative double-blind study of a 0.1% hydrocortisone-17-butyrate cream (Locoid) and a 0.1% betamethasone-17-valerate cream (Betnovate) in patients with noninfected eczema].
    von Fischer F
    Ther Umsch; 1984 Jun; 41(6):429-32. PubMed ID: 6379975
    [No Abstract]   [Full Text] [Related]  

  • 20. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.